Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:57 AM
Ignite Modification Date:
2025-12-26 @ 10:57 AM
NCT ID:
NCT00264108
Eligibility Criteria:
Inclusion Criteria:
* Patients with a diagnosis of solid tumors, multiple myeloma (Kahlers' disease), non-Hodgkin lymphoma or Hodgkins' disease
* Patients must already be receiving chemotherapy or start their first cycle within a week of enrollment
* Patients must receive either epoetin alfa or darbepoetin alfa treatment (expected treatment duration is at least 4 weeks)
Exclusion Criteria:
* Patients not meeting all of the inclusion criteria for entry into the study
* Patients who cannot read the Dutch language and/or do not understand the Dutch Informed Consent Form
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00264108
Study Brief:
Protocol Section:
NCT00264108